Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Journal of the American College of Cardiology

Volumn 69, Issue 2, 2017, Pages 176-185

  Vaduganathan, Muthiah ^a   Harrington, Robert A ^b   Stone, Gregg W ^c   Deliargyris, Efthymios N ^d   Steg, Ph Gabriel ^e,f   Gibson, C Michael ^g   Hamm, Christian W ^h   Price, Matthew J ⁱ   Menozzi, Alberto ^j,l,l   Prats, Jayne ^d   Elkin, Steven ^d   Mahaffey, Kenneth W ^b   White, Harvey D ^k,l   Bhatt, Deepak L ^a   Cura, Fernando ^l   Ballarino, Miguel ^l   Damonte, Anibal Agustín ^l   Grinfeld, Diego ^l   Álvarez, Carlos Alejandro ^l   Fernandez, Alberto ^l   Farshid, Ahmad ^l   Gunalingam, Brendan ^l   Jeurgens, Craig ^l   Lowe, Harry ^l   Hallani, Hisham ^l   Nelson, Greg ^l   New, Gishel ^l   Dick, Ronald ^l   Lefkovits, Jeffrey ^l   Duffy, Stephen ^l   Bett, Nick ^l   Yadav, Raibhan ^l   Garrahy, Paul ^l   Lehman, Ron ^l   Aylward, Philip ^l   Horowitz, John ^l   Worthley, Matthew ^l   Cross, David ^l   Rankin, Jaime ^l   Thompson, Peter ^l   Roberts Thomson, Phil ^l   Jayasinghe, Rohan ^l   Aroney, Con ^l   Huber, Kurt ^l,l   Leisch, Franz ^l   Altenberger, Johann ^l   Gaul, Georg ^l   Neunteufl, Thomas ^l   Weidinger, Franz ^l   Schuchlenz, Herwig ^l   Weber, Heinrich ^l   Benzer, Werner ^l   Rossi, Paulo ^l   Almeida, Breno ^l   Godinho, Antonio ^l   Vilas Boas, Fabio ^l   Vacanti, Luciano ^l   Serpa, Renato ^l   Jatene, José Antonio ^l   Reis, Gilmar ^l   Saad, Jamil ^l   Marino, Marcos ^l   Botelho, Roberto ^l   Costantini, Constantino ^l   Wang, Ricardo ^l   Precoma, Dalton ^l   Rati, Miguel ^l   Bodanese, Luis ^l   Manenti, Euler ^l   Zouvi, João Paulo ^l   Tumelero, Rogerio ^l   Herdy, Arthur ^l   Filho, Eulogio Martinez ^l   Carvalho, Antônio ^l   Franken, Roberto ^l   Title, Lawrence ^l   Lazzam, Charles ^l   Reeves, Francois ^l,l   Shaburishvili, Tamaz ^l,l   Chapidze, Gulnara ^l,l   Mamatsashvili, Merab ^l,l   Khintibidze, Irakli ^l   Heuer, Hubertus ^l,l   Olbrich, Hans Georg ^l   Genth Zotz, Sabine ^l,l   Moebius Winkler, Sven ^l   Buerke, Michael ^l   Hoffmann, Stefan ^l,l   Radke, Peter ^l,l   Moellmann, Helge ^l   Katus, Hugo ^l   Voehringer, Hans Friedrich ^l   Hengstenberg, Christian ^l   Klauss, Volker ^l   Brachmann, Johannes ^l   Khan, Aftab ^l   Kumar, Sampath ^l   Mohanan, Padinhare ^l   Chandra, Praveen ^l   Rao, Maddury ^l   Ramesh, S S ^l   Parikh, Keyur ^l   Srinivas, Arun ^l   Sinha, Nakul ^l   Prakash, V S ^l   Hiremath, Shirish ^l   Mishra, Anil ^l   Roy, Sanjeeb ^l   Sethi, Kamal ^l   Mehta, Ashwani ^l   Patel, Tejas ^l   Bhandari, Suman ^l   Gadkari, Milind ^l   De Servi, Stefano ^l,l   Musumeci, Giuseppe ^l,l   Cortese, Bernardo ^l   Marenzi, Giancarlo ^l   De Caterina, Raffaele ^l   Stewart, Ralph ^l,l   Devlin, Gerard ^l,l   Harding, Scott ^l   Elliott, John ^l   Wilkins, Gerard ^l   Scott, Douglas ^l,l   Dobrzycki, Slawomir ^l   Dorniak, Waldemar ^l   Dudek, Dariusz ^l   Gasior, Zbigniew ^l   Hiczkiewicz, Jaroslaw ^l   Kornacewicz Jach, Zdzislawa ^l,l   Kubik, Leszek ^l   Kuc, Krzysztof ^l   Kuzniar, Jerzy ^l   Mazurek, Walentyna ^l   Ostrowski, Jakub ^l   Tendera, Michal ^l   Wisniewski, Andrzej ^l   Zinka, Elzbieta ^l,l   Zmudka, Krzysztof ^l   Pawła, Jana ^l   Kosmider, Maciej ^l   Seweryna, ^l   Melgares, Rafael ^l   Goicolea, Francisco ^l   Hernandez, Jose ^l   Zueco, Javier ^l   Kraiz, Igor ^l   Vatutin, Mykola ^l   Polyakov, Anatoliy ^l   Sokolov, Yury ^l   House, Kenneth ^l   Campbell, Charles ^l   Trageser, Timothy ^l   Baran, Kenneth ^l   Kleiman, Neal ^l   Medina, Roberto ^l   Hill, Roger ^l   Jafar, M Zubair ^l   Drenning, David ^l   Ladley, Herbert ^l   Nahhas, Ahed ^l   Niederman, Alan ^l   Goyal, Amit ^l   Abernethy, William ^l   Jaffrani, Naseem ^l   Zelman, Richard ^l   Negus, Brian ^l,l   Marquez, Jose ^l   Mahmud, Ehtisham ^l   French, William ^l,l   Paulowski, John ^l   Pollack, Charles ^l   Mines, Mark ^l   Federici, Robert ^l   Schweiger, Marc ^l   Habet, Kalim ^l   Quintana, Ofsman ^l   Nygaard, Thomas ^l,l   Orlow, Steve ^l   Spriggs, Douglas ^l,l   Chavez, Ivan ^l   Warner, Mark ^l   Paulus, Richard ^l,l   Cochran, David ^l   Hirsch, Cary ^l   Virmani, Ajay ^l   Soukas, Peter ^l   Srivastava, Nalin ^l   Ferrier, L Norman ^l   Kini, Annapoorna ^l   Greenberg, Mark ^l   Herrmann, Howard ^l   Fernandes, Valerian ^l   Bertolet, Barry ^l   Waksman, Ron ^l   Henderson, Joseph ^l   Gogia, Harinder ^l,l   Amine, Maged ^l,l   Mastali, Kourosh ^l   Stuckey, Thomas ^l,l   Hui, Peter ^l   Pacifico, Luigi ^l   Caulfield, Todd ^l   Ginete, Wilson ^l   Ballard, William ^l   Iwaoka, Robert ^l,l   Stella, Joseph ^l   Misra, Vijay ^l   Andreou, Costa ^l   Voeltz, Michele ^l,l,l   Batchelor, Wayne ^l   Staniloae, Cezar ^l   Gips, Sanford ^l   Kramer, Jeffrey ^l   Mahoney, Paul ^l   Wang, John ^l   Gogo, Prospero ^l,l   Rizik, David ^l,l   Winters, Rex ^l   MacKenzie, Garry ^l   Jenkins, Stephen ^l   Teirstein, Paul ^l   Leimgruber, Pierre ^l,l   Scott, J Christopher ^l,l,l   Krauss, Seth ^l   Rohrbeck, Steven ^l   Martin, Robert ^l   Grieco, Gustavo ^l   Cannon, Louis ^l   Westerhausen, Don ^l   Fortuin, F David ^l   Schulman, Steven ^l   Cohn, Joel ^l   McLaurin, Brent ^l,l   Saucedo, Jorge ^l,l   Wozniak, Robert ^l   Hall, Jack ^l   Marzo, Kevin ^l   Krolick, Merrill ^l   Gimple, Lawrence ^l,l   Hockstad, Eric ^l   Rodriguez, Arsenio ^l,l   Kao, John ^l,l   Shroff, Adhir ^l,l,l   Attubato, Michael ^l   Quesada, Ramon ^l   Rivera, Ernesto ^l,l   Kereiakes, Dean ^l   Raymond, Russell ^l   Amidon, Thomas ^l   Lee, David ^l   King, Spencer ^l   Douglas, John ^l,l   Jain, Abnash ^l   Kleaveland, J Patrick ^l   Driesman, Mitchell ^l   Kumar, Krishna ^l   Kowalchuk, Glen ^l   Taghizadeh, Behzad ^l   Barr, Lawrence ^l   Benzuly, Keith ^l   Helmy, Tarek ^l   Pinto, Duane ^l   Aragon, Joseph ^l   Low, Reginald ^l,l   Horwitz, Phillip ^l   LeGalley, Thomas ^l   Angiolillo, Dominick ^l,l,l   Sachdeva, Rajesh ^l   Kent, Kenneth ^l   Gruberg, Luis ^l,l   Bach, Richard ^l,l   Pow, Thomas ^l   O'Shaughnessy, Charles ^l   Wong, Shing ^l   Shaikh, Saeed R ^l   Reitman, Arthur ^l   Lawrence, Mark ^l   Escudero, Alejandro Garcia ^l   Poy, Carlos ^l   Miceli, Miguel ^l   Pocovi, Antonio ^l   Londero, Hugo ^l   Baccaro, Jorge ^l   Polonetsky, Leonid ^l   Karotkin, Aliaksey ^l   Shubau, Leanid ^l   Maffini, Eduardo ^l   Machado, Bruno ^l   Airton, José ^l   Lima, Valter ^l   Jatene, Jose ^l   Perin, Marco ^l   Caramori, Paulo ^l   Castro, Iran ^l   Manukov, Ivan ^l   Grigorov, Mladen ^l   Milkov, Plamen ^l   Jorgova, Julia ^l   Georgiev, Svetoslav ^l   Rifai, Nizar ^l   Doganov, Alexander ^l   Petrov, Ivo ^l,l   Hui, William ^l   Tanguay, Jean Francois ^l   Richter, Marek ^l   Tousek, Frantisek ^l,l   Klimsa, Zdenek ^l   Padour, Michal ^l   Mrozek, Jan ^l,l   Branny, Marian ^l   Coufal, Zdenek ^l,l   Simek, Stanislav ^l,l   Rozsival, Vladimir ^l   Pleva, Leos ^l   Stasek, Josef ^l   Kala, Petr ^l,l   Groch, Ladislav ^l   Kocka, Viktor ^l,l   Jain, Rajesh ^l   Banker, Darshan ^l   Krishna, Lanka ^l   Joshi, Hasit ^l   Arneja, Jaspal ^l   Grinius, Virgilijus ^l   Norkiene, Sigute ^l   Petrauskiene, Birute ^l   Michels, Rolf ^l   Tjon, Melvin ^l   de Swart, Hans ^l   de Winter, Robbert ^l   Abernethey, Malcolm ^l   Osiev, Alexander ^l   Linev, Kirill ^l,l   Kalinina, Svetlana ^l,l   Baum, Svetlana ^l   Kosmachova, Elena ^l,l   Shogenov, Zaur ^l,l   Markov, Valentin ^l,l   Boldueva, Svetlana ^l   Barbarash, Olga ^l   Kostenko, Victor ^l   Vasilieva, Elena ^l   Gruzdev, Aleksey ^l   Lusov, Victor ^l   Dovgalevsky, Pavel ^l   Azarin, Oleg ^l   Chernov, Sergey ^l   Smolenskaya, Olga ^l   Duda, Alexey ^l   Fridrich, Viliam ^l   Hranai, Marian ^l   Studenčan, Martin ^l   Kurray, Peter ^l   Bennett, John ^l   Blomerus, Pieter ^l   Disler, Laurence ^l   Engelbrecht, Johannes ^l   Klug, Eric ^l   Routier, Robert ^l   Venter, Tjaart ^l   Van Der Merwe, Nico ^l   Becker, Anthony ^l   Cha, Kwang Soo ^l   Lee, Seung Hwan ^l   Han, Sang Jin ^l   Youn, Tae Jin ^l   Hur, Seung Ho ^l   Seo, Hong Seog ^l   Park, Hun Sik ^l   Rhim, Chong Yun ^l   Pyun, Wook Bum ^l   Choe, Hyunmin ^l   Jeong, Myung Ho ^l   Park, Jong Seon ^l   Shin, Eak Kyun ^l   Hernández, Felipe ^l   Figueras, Jaume ^l   Hernández, Rosana ^l   López Minguez, José Ramón ^l   González Juanatey, José Ramón ^l   Palop, Ramón López ^l   Galeote, Guillermo ^l   Chamnarnphol, Noppadol ^l,l   Buddhari, Wacin ^l   Sansanayudh, Nakarin ^l   Kuanprasert, Srun ^l,l   Penny, William ^l   Lui, Charles ^l   Grimmett, Garfield ^l   Srinivasan, Venkatraman ^l   Ariani, Kevin ^l   Khan, Waqor ^l   Blankenship, James ^l,l   Eisenberg, Steven ^l   Greenberg, Jerry ^l   Breall, Jeffrey ^l   Chandna, Harish ^l   Tolerico, Paul ^l   Nseir, Georges ^l   Greenbaum, Adam ^l   Istfan, Pierre ^l   Sklar, Joel ^l   Smith, Robert ^l   Xenopoulos, Nicholaos ^l   Mulumudi, Mahesh ^l   Hoback, James ^l   Eaton, Gregory ^l   Griffin, John ^l   Ebrahimi, Ramin ^l   Lundstrom, Robert ^l   Temizer, Dogan ^l,l   Tam, Kenneth ^l   Suarez, Jose ^l,l   Raval, Amish ^l   Kaufman, Jay ^l   Brilakis, Emmanouil ^l,l   Stillabower, Michael ^l,l   Quealy, Kathleen ^l   Nunez, Boris ^l   Samuels, Bruce ^l   Argenal, Agustin ^l   Srinivas, Vankeepuram ^l   Rosenthal, Andrew ^l   Tummala, Pradyumna ^l   Myers, Paul ^l   LaMarche, Nelson ^l   Chan, Michael ^l,l   Simon, Daniel ^l   Kettelkamp, Richard ^l   Schaer, Gary ^l   Kosinski, Edward ^l   Buchbinder, Maurice ^l   Sharma, Mukesh ^l   Goodwin, Mark ^l   Mann, J Tift ^l   Holmes, David ^l   Rao, Sunil ^l   Azrin, Michael ^l   Gammon, Roger ^l   Mavromatis, Kreton ^l   Ahmed, Abdel ^l   Zughaib, Marcel ^l   Westcott, R Jeffrey ^l   Jain, Ash ^l   Delle Karth, Georg ^l   Saad, Jamil Abdalla ^l   Abizaid, Alexandre ^l   Areas, Carlos Augusto Formiga ^l   Ribeiro, Expedito E ^l   Dos Santos, Fabio Rossi ^l   Tumelero, Rogerio Tadeu ^l   Botelho, Roberto Vieira ^l   Atzev, Borislav ^l   Boichev, Boicho ^l   Grigorov, Georgi ^l   Penkov, Nikolay ^l   Zehirov, Boris ^l   Cervinka, Pavel ^l   Hajek, Petr ^l   Horak, David ^l   Kmonicek, Petr ^l   Sitar, Jan ^l   Emukhvari, Nodar ^l   Khabeishvili, George ^l   Behrens, Steffen ^l   Darius, Harald ^l   Dissmann, Martin ^l   Fichtlscherer, Stephan ^l   Franz, Wolfgang ^l   Geisler, Tobias ^l   Goldmann, Britta ^l   Mugge, Andreas ^l   Poerner, Tudor ^l   Richardt, Gert ^l   Stellbrink, Christoph ^l   Werner, Nikos ^l   Bramucci, Ezio ^l   Galasso, Gennaro ^l   Picchi, Andrea ^l   Presbitero, Patrizia ^l   Sasse, Alexander ^l   Andrzej, Szyszka ^l   Dubaniewicz, Witold ^l   Kasprzak, Jaroslaw ^l   Kleinrok, Andrzej ^l   Rynkiewicz, Andrzej ^l   Sosnowski, Cezary ^l   Targonski, Radoslaw ^l   Trebacz, Jaroslaw ^l   Witkowski, Adam ^l   Dovgalevsky, Yakov ^l   Gordeev, Ivan ^l   Pavlov, Prokhor ^l   Shalaev, Sergey ^l   Sukmanova, Irina ^l   Yakovlev, Alexey ^l   Boonbaichaiyapruck, Sarana ^l   Kaewsuwanna, Pinij ^l   Piyayotai, Dilok ^l   Arif, Imran ^l   Cinderella, Joseph ^l   Davis, Brent ^l   Devireddy, Chandanreddy ^l   Dorogy, Mark ^l   Ferrier, Norman ^l   Fisher, Daniel ^l   Foster, Robert ^l   Galla, John ^l   Gollapudi, Raghava ^l   Hermiller, James ^l   Heuser, Richard ^l   Jafar, Zubair ^l   Kimmelstiel, Carey ^l   Kinlay, Scott ^l   Leggett, James ^l   Letts, Dustin ^l   Lipsitt, Michael ^l   Martinez Arraras, Joaquin ^l   Mayhew, Marc ^l   McWhirter, Paul ^l   Mirza, Ayoub ^l   O'Riordan, William ^l   Petersen, John ^l   Picon, Hector ^l   Picone, Mark ^l   Price, Matthew ^l   Sethi, Virender ^l   Siegel, Craig ^l   Steinberg, Daniel ^l   Tauth, Jeffrey ^l   Vidovich, Mladen ^l   Waltman, Jonathan ^l   Wilensky, Michael ^l   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine   (United States)

^d MEDICINES COMPANY   (United States)

^e INSERM   (France)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h Kerckhoff Heart and Thorax Center   (Germany)

ⁱ SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^j UNIVERSITY HOSPITAL OF PARMA   (Italy)

^k Cardiovascular Service   (New Zealand)

^l NONE

more..

Author keywords

antiplatelet therapy; bleeding; coronary artery disease; outcomes

Indexed keywords

CANGRELOR; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; ACETYLSALICYLIC ACID; ADENOSINE PHOSPHATE; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; TICLOPIDINE;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; AGED; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COHORT ANALYSIS; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADENOSINE MONOPHOSPHATE; AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; COHORT STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 85008627203     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.10.055     Document Type: Article

References (26)

1. 1 Généreux, P., Stone, G.W., Harrington, R.A., et al., for the CHAMPION PHOENIX Investigators. Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). J Am Coll Cardiol 63 (2014), 619–629.
2. 2 Součková, L., Opatřilová, R., Suk, P., et al. Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR). Eur J Clin Pharmacol 69 (2013), 309–317.
3. 3 Heestermans, A.A., van Werkum, J.W., Taubert, D., et al. Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction. Thromb Res 122 (2008), 776–781.
4. 4 Sethi, A., Bajaj, A., Bahekar, A., et al. Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction: a meta-regression of randomized controlled trials. Catheter Cardiovasc Interv 82 (2013), 171–181.
5. 5 Safley, D.M., Venkitachalam, L., Kennedy, K.F., et al. Impact of glycoprotein IIb/IIIa inhibition in contemporary percutaneous coronary intervention for acute coronary syndromes: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv 8 (2015), 1574–1582.
6. 6 Levine, G.N., Bates, E.R., Blankenship, J.C., et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 67 (2016), 1235–1250.
7. 7 Steg, P.G., Bhatt, D.L., Hamm, C.W., et al., for the CHAMPION Investigators. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382 (2013), 1981–1992.
8. 8 Harrington, R.A., Stone, G.W., McNulty, S., et al. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med 361 (2009), 2318–2329.
9. 9 Bhatt, D.L., Lincoff, A.M., Gibson, C.M., et al., for the CHAMPION PLATFORM Investigators. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med 361 (2009), 2330–2341.
10. 10 Bhatt, D.L., Stone, G.W., Mahaffey, K.W., et al., for the CHAMPION PHOENIX Investigators. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 368 (2013), 1303–1313.
11. 11 Thygesen, K., Alpert, J.S., White, H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007), 2634–2653.
12. 12 Cutlip, D.E., Windecker, S., Mehran, R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007), 2344–2351.
13. 13 Bhatt, D.L., Intensifying platelet inhibition: navigating between Scylla and Charybdis. N Engl J Med 357 (2007), 2078–2081.
14. 14 Bhatt, D.L., Glycoprotein IIb/IIIa inhibitors: do they still have a role?. J Am Coll Cardiol 57 (2011), 1200–1201.
15. 15 Bhatt, D.L., Topol, E.J., Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 284 (2000), 1549–1558.
16. 16 Eikelboom, J.W., Mehta, S.R., Anand, S.S., et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 (2006), 774–782.
17. 17 Rao, S.V., Jollis, J.G., Harrington, R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004), 1555–1562.
18. 18 Rao, S.V., Kaul, P.R., Liao, L., et al. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 155 (2008), 369–374.
19. 19 Steg, P.G., van ‘t Hof, A., Hamm, C.W., et al., for the EUROMAX Investigators. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 369 (2013), 2207–2217.
20. 20 Stone, G.W., Witzenbichler, B., Guagliumi, G., et al., for the HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008), 2218–2230.
21. 21 Vaduganathan, M., Harrington, R.A., Stone, G.W., et al. Variation in patient profiles and outcomes in US and non-US subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial. Circ Cardiovasc Interv, 9, 2016, e003612.
22. 22 O'Donoghue, M., Antman, E.M., Braunwald, E., et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol 54 (2009), 678–685.
23. 23 Wallentin, L., Becker, R.C., Budaj, A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361 (2009), 1045–1057.
24. 24 White, H.D., Bhatt, D.L., Gibson, C.M., et al. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). J Am Coll Cardiol Intv 8 (2015), 424–433.
25. 25 Gutierrez, J.A., Harrington, R.A., Blankenship, J.C., et al., for the CHAMPION PHOENIX Investigators. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX. Eur Heart J 37 (2016), 1122–1130.
26. 26 Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.